Formyl Peptide Receptor Activation Elicits Endothelial Cell Contraction and Vascular Leakage by Camilla F. Wenceslau et al.
August 2016 | Volume 7 | Article 2971
HypotHesis and tHeory
published: 02 August 2016
doi: 10.3389/fimmu.2016.00297
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Kiyoshi Itagaki, 
Harvard Medical School, USA
Reviewed by: 
Peter Monk, 
University of Sheffield, UK  
Michael Francis Marusich, 
mAbDx, Inc., USA
*Correspondence:
Camilla F. Wenceslau  
camillawenceslau@hotmail.com
Specialty section: 
This article was submitted to 
Molecular Innate Immunity, 
a section of the journal 
Frontiers in Immunology
Received: 03 June 2016
Accepted: 22 July 2016
Published: 02 August 2016
Citation: 
Wenceslau CF, McCarthy CG and 
Webb RC (2016) Formyl Peptide 
Receptor Activation Elicits Endothelial 
Cell Contraction and Vascular 
Leakage. 
Front. Immunol. 7:297. 
doi: 10.3389/fimmu.2016.00297
Formyl peptide receptor activation 
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and Vascular Leakage
Camilla F. Wenceslau*, Cameron G. McCarthy and R. Clinton Webb
Department of Physiology, Augusta University, Augusta, GA, USA
The major pathophysiological characteristic of systemic inflammatory response syn-
drome (SIRS) and sepsis is the loss of control of vascular tone and endothelial barrier 
dysfunction. These changes are attributed to pro-inflammatory mediators. It has been 
proposed that in patients and rats without infection, cell components from damaged 
tissue are the primary instigators of vascular damage. Mitochondria share several 
characteristics with bacteria, and when fragments of mitochondria are released into the 
circulation after injury, they are recognized by the innate immune system. N-Formyl pep-
tides are common molecular signatures of bacteria and mitochondria and are known to 
play a role in the initiation of inflammation by activating the formyl peptide receptor (FPR). 
We have demonstrated that infusion of mitochondrial N-formyl peptides (F-MIT) leads to 
sepsis-like symptoms, including vascular leakage. We have also observed that F-MIT, 
via FPR activation, elicits changes in cytoskeleton-regulating proteins in endothelial cells. 
Therefore, we hypothesize that these FPR-mediated changes in cytoskeleton can cause 
endothelial cell contraction and, consequently vascular leakage. Here, we propose that 
endothelial FPR is a key contributor to impaired barrier function in SIRS and sepsis 
patients following trauma.
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introdUCtion
Systemic inflammatory response syndrome (SIRS) and sepsis are the principal causes of death in 
intensive care units, with mortality rates between 30 and 70% (1–3) The diagnosis of sepsis requires 
confirmation of bacterial growth in blood cultures, as well as the presence of two or more of the 
following symptoms: hypothermia or hyperthermia, tachycardia, tachypnea, and leukocytopenia 
or leukocytosis (1, 2). It is noteworthy that only about one-third to one-half of patients meeting 
these criteria were subsequently confirmed to have sepsis (1–3). Accordingly, all remaining patients 
are diagnosed with SIRS, a sepsis-like condition. Therefore, diagnosis of SIRS requires the same 
symptoms, minus the presence of infection. One major pathophysiological characteristic of SIRS 
and sepsis is the breakdown of the endothelial barrier function results in the loss of fluid into the 
extravascular space that leads to edema in several tissues (1, 2, 4).
The circulatory responses to sepsis are characterized by an initial hyperdynamic phase, where 
there is a reduction in systemic vascular resistance due to peripheral vasodilation and unrespon-
siveness to vasoconstrictor drugs are observed (5). Later, the myocardial dysfunction caused by 
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pro-inflammatory mediators leads to a hypodynamic phase, 
where cardiac output significantly falls and both the systolic 
and the diastolic functions of the heart are greatly impaired (5). 
The endothelium lining of the vascular walls is a major target 
of sepsis, especially during the initial hyperdynamic phase, and 
damage of endothelial cells accounts for much of the pathology of 
septic shock (4, 5). The increase in endothelial permeability and 
dysfunction has been associated with several factors, including 
hypoxia, oxidative stress and augmented TNF-α levels (4). Other 
interleukins (e.g., IL-1, IL-2, and IL-6) are also contributors (6). 
In line, IL-6 is known to be a clinically suitable biomarker for 
sepsis, and Waage and coworkers (7) observed high levels of IL-6 
and its association with sepsis in patients with meningococcal 
infection (7). Corroborating these data, Lo and others (8) dem-
onstrated that IL-6 induced redistribution of vascular-endothelial 
cadherin, which is the major component of endothelial adhesion 
and barrier function via adherens junctions. Vascular endothe-
lial cadherin-regulated protein complexes that join adjacent 
endothelial cells and prevent leukocyte emigration and vascular 
leakage (6, 8). Therefore, disruption of vascular endothelial 
cadherins function results in trans-endothelial flow of fluid and 
interstitial edema. Also, it has been observed that other mol-
ecules released during acute inflammation such as bradykinin, 
thrombin, VEGF, and histamine result in endothelial activation 
and massive increases in glycocalyx expression of endothelial 
leukocyte adhesion molecule 1, intercellular adhesion molecule 
1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1) 
(9). The increased expression of these proteins leads to leukocyte 
rolling, adherence, and migration, which initiate the inflamma-
tory damage to endothelium and endo organs (9). Furthermore, 
it is well known that exacerbated production of nitric oxide by 
the inducible form of nitric oxide synthase (iNOS) contributes to 
vascular leakage and hyporeactivity. Nevertheless, pharmacologi-
cal interventions using NOS inhibitors have not been successful. 
Currently, there are no therapies for blocking vascular leakage in 
SIRS and sepsis, given that the molecular mechanisms regulating 
vascular permeability are not completely understood.
Contraction of endothelial Cell: a new 
paradigm for the regulation of Vascular 
Leakage
Although the concept that active contraction of endothelial 
cells was first suggested by Majno in 1961 (10, 11), currently the 
intracellular events regulating endothelial contractile activity 
is still unknown. Just like in other type of cells, the dynamic 
assembly, disassembly, and reorganization of the actin and 
myosin cytoskeleton regulate endothelial cells contraction (12). 
Accordingly, Goeckeler and Wysolmerski (12) reported that 
thrombin stimulation results in rapid sustained isometric con-
traction in endothelial cells that increases twofold within 5 min 
and remains elevated for 60 min. Also, they observed that myosin 
light chain (MLC) phosphorylation precedes the development 
of isometric tension (12). Supporting these data, it has been 
shown that transfection of constitutively active MLCK induces 
MLC phosphorylation associated with increase in permeability 
in endothelial cells (13). On the other hand, inhibition of MLC 
phosphorylation with an MLCK antagonist greatly attenuates the 
increase in venular permeability in response to soluble inflamma-
tory mediators (14).
More recently, it has been demonstrated that not only the 
interaction of actin and myosin is necessary for endothelial 
contraction but also changes in actin polymerization have been 
associated with the development of isometric force. In many 
cell types, including endothelial cells, the actin cytoskeleton is 
a highly dynamic structure that undergoes polymerization and 
depolymerization based upon cellular demand (15). It is known 
that actin polymerization occurs in two steps, nucleation and 
elongation. Nucleation occurs when three actin monomers bind 
together and provides a site for elongation. Elongation occurs 
when ATP bound globular (G)-actin binds and grows to form 
filamentous (F)-actin (15). Reorganization of F-actin, which is 
a fundamental unit for actin-based cytoskeleton structures, is 
paramount for endothelial cell contraction and barrier function. 
Several permeability factors, including angiogenic and inflam-
matory mediators, trigger signaling pathway in endothelial 
cell that enhance F-actin polymerization and actomyosin 
contractility.
It well known that Rho family of p21 small GTP-binding 
proteins are associated with the direct regulation of actin 
cytoskeleton (16). RhoA induces actin polymerization at focal 
adhesions by activating formin-homology protein Dia1, a potent 
activator of nucleation and elongation of actin filaments, and 
inhibits actin filament disassembly by inactivation of ADF/
cofilin, a family of actin-binding proteins, which disassembles 
actin filaments. Additionally, RhoA promotes contractility by 
activating the myosin light-chain kinase through ROCK kinase 
(17). An interesting study by Gorovoy et al. (18) provide strong 
evidence that increased RhoA activity results in vascular leakage 
in mouse lung. In this study, it was observed that increased RhoA 
activity due to deletion of one its inhibitory proteins, RhoGDI, 
causes a loss of endothelial junctional integrity and breakdown 
in endothelial barrier function (18).
Mitogen-activated protein (MAP) kinases are a family of stress 
activated enzymes that initiate signaling cascades in response to 
several stimuli, including inflammation and injury. It has previ-
ously shown that p38 MAPK kinase leads to reorganization of the 
actin cytoskeleton to form stress fibers and increase in vascular 
permeability (19). Furthermore, It was demonstrated in a recently 
study by using atomic force microscopy and a combination of 
confocal microscopy methods that thermal injury induces 
venular hyperpermeability and that serum from burned rats 
induces endothelium cells actin rearrangement and contraction 
(20). However, inhibition of the p38 MAPK ameliorates resulting 
vascular dysfunction by significantly reducing endothelial cells 
contraction (20).
Despite new information about the pathophysiology of 
molecular mechanisms regulating vascular permeability, this 
disruption continues to be treated inappropriately and this con-
tributes to an unacceptably high mortality rate in patients with 
SIRS and sepsis. Therefore, understanding vascular function 
and the causes for this disturbance would ultimately provide 
starting points for therapies designed to treat these devastating 
diseases.
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Mitochondrial N-Formyl peptides, Formyl 
peptide receptor, and endothelial Cell 
Cytoskeleton
It has been proposed that in patients and rats without infection, 
cell components from damaged tissue can initiate the genesis 
of SIRS (21–25). These cell components are collectively called 
damage-associated molecular patterns (DAMPs). DAMPs are 
endogenous molecules that are released from cells following 
injury. For evolutionary reasons, mitochondria share several 
characteristics with bacteria, and when fragments of mitochon-
dria are released into the circulation, they are recognized by the 
innate immune system. Due to protein translation initiation by 
formyl-methionine in both bacteria and mitochondria, N-formyl 
peptides are common molecular signatures of bacteria and mito-
chondria and are known to play a role in the initiation of inflam-
mation by activating the formyl peptide receptor (FPR) (22, 26, 
27). The FPR has been identified as a subfamily of G-protein-
coupled receptors (27). FPR-1 and FPR-2 are expressed at high 
levels on leukocytes and mediate cell chemotaxis (27). However, 
it has been demonstrated that mitochondrial DAMPs suppress 
pulmonary immune response via FPR-1 and -2 (28). FPR activa-
tion leads to cytoskeletal rearrangements, making N-formyl 
peptides potent inducers of neutrophil F-actin formation. 
Stimulation of human neutrophils with the formylated peptide 
(fMLP, bacteria derived), known to result in a prompt rise of the 
calcium, also induced a rapid decrease of G-actin content and 
increase of filamentous actin, F-actin, content (29). A reduction 
of the fMLP induced calcium transient to about 25 nM, resulted 
in a less pronounced decrease of G-actin content and increase of 
F-actin content (30). FPR activation has also been demonstrated 
to signal through the Rho family protein cell division control 
protein 42 (Cdc42) to activate Rac- and ARP2/3-dependent 
pathways leading to actin nucleation (30). Recent evidence 
suggests that FPR is a membrane mechanosensor that senses 
the mechanical fluid stress and signals intracellular cascades. 
Blockage of FPR reduces pseudopod retraction response to fluid 
stress in neutrophils (31).
It is known though, that a major mechanism by which immune 
system causes organ damage is due to neutrophil-mediated 
increases in endothelial cell permeability. Nevertheless, in a 
recent study from Sun and collaborators (32) demonstrated that 
mitochondrial DNA isolated from human liver induced dose-
dependent rise in endothelial permeability both in the presence 
and absence of neutrophils (32). In the absence of neutrophils, 
however, permeability changes were transient and decayed 
relatively quickly. In the presence of neutrophils, the increases 
in permeability were sustained and even intensified over time. 
In addition, Sun et al. demonstrated that non-formylated mito-
chondrial proteins cause changes in endothelial cell permeability 
directly. However, bacteria-derived fMLP did not induce any 
change in endothelial permeability (32).
We have observed that both mitochondrial N-formyl peptides 
(formylated peptide corresponding to the NH2-terminus of 
mitochondria NADPH dehydrogenase subunit 6; F-MIT) and 
fMLP (bacteria derived) induce vascular leakage and exacerbated 
vasodilatation in resistance arteries, and that a FPR antagonist 
inhibits these responses (22). F-MIT, but not non-formylated 
peptides or mitochondrial DNA, induced severe hypotension via 
FPR activation and histamine release (22). Supporting these data, 
rats that underwent hemorrhagic shock increased plasma levels 
of F-MIT associated with lung damage, and antagonism of FPR 
ameliorated this response.
As described above, FPR activation leads to cytoskeleton rear-
rangement in immune and non-immune cells. Therefore, because 
FPR is present in endothelial cells and because we observed that 
F-MIT induces vascular leakage due to FPR activation (22), we 
questioned if F-MIT via FPR activation could lead to changes in 
cytoskeleton-regulating proteins in primary cultures of human 
aortic endothelial cells (HAEC). To answer this question, we 
treated HAEC with F-MIT (20  min, 10  μM) in the presence 
or absence of a cocktail of FPR antagonists (FPR-1 antagonist, 
cyclosporine H: CsH, 1 μmol/L and FPR-2 antagonist, WRW4, 
10  μmol/L). Treatment with F-MIT rapidly increased RhoA/
ROCK (Rho: 1.8-fold vs. Veh; ROCK: 1.4-fold vs. Veh, p < 0.05), 
CDC42 (twofold vs. Veh, p <  0.05), and phospho-MLC Thr/
Ser19 (1.5-fold vs. Veh, p < 0.05) in HAEC. These changes were 
abolished in the presence of FPR antagonist. These data suggest 
that F-MIT leads to changes in endothelial cell cytoskeleton inde-
pendent of leukocyte activation. Given that we provided strong 
evidence FPR induced RhoA and CDC42 expression, and these 
proteins are linked with endothelial contraction via actin polym-
erization, we infer that F-MIT elicits endothelial contraction and 
subsequent vascular leakage not only via actomyosin interaction 
but also via actin polymerization.
HypotHesis
Our new mechanistic hypothesis is that F-MIT released from 
trauma/cell damage activate FPR leading to changes in endothe-
lial cell cytoskeleton which subsequently induces endothelial 
contraction and vascular permeability (Figure 1).
evaluation of the Hypothesis
The inability to treat or prevent SIRS and sepsis in trauma patients 
may be due to our limited understanding of the molecular path-
ways that govern the disruption of normal vascular control and 
responsiveness. The proposed hypothesis is significant because it 
may offer a novel cellular and molecular mechanism underlying 
the development of arterial dysfunction in SIRS and extend our 
knowledge about how mitochondria-derived molecules mediate 
endothelial barrier dysfunction.
In the present study, we have observed that F-MIT, via FPR 
activation, elicits changes in cytoskeleton-regulating proteins in 
endothelial cells. Therefore, we infer that this interaction can 
lead to endothelial contraction, increased vascular leakage, 
and attenuated barrier function as observed in SIRS patients 
following trauma. Corroborating this hypothesis, we previously 
observed that F-MIT induced vascular leakage in conduit and 
resistance arteries from Wistar rats (22). Based on these find-
ings, it is reasonable to speculate that in conditions of enhanced 
FPR activation (e.g., tissue damage/trauma), FPR-associated 
signaling leads increases in endothelial permeability, which 
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FiGUre 1 | Mitochondrial N-formyl peptides (FMit) trigger endothelial cell contraction and vascular leakage via formyl peptide receptor (Fpr) 
activation, contributing to the loss of control of vascular tone and edema in trauma-induced sirs and sepsis.
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subsequently contributes to end organ damage. Therefore, we 
believe that the FPR may be a target for the treatment of SIRS 
and sepsis.
aUtHor ContriBUtions
CW analyzed the data in HAEC and wrote, discussed, and 
reviewed the manuscript. CM performed the experiments in 
HAEC, discussed, and reviewed the manuscript. RW reviewed 
the manuscript.
aCKnoWLedGMents
We thank Dr. Kiyoshi Itagaki for the invitation to write this 
hypothesis article.
FUndinG
This work was funded by American Heart Association 
(#14POST20490292 and #13PRE14080019) and National 
Institutes of Health.
reFerenCes
1. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. 
Nat Med (2003) 9:517–24. doi:10.1038/nm0503-517 
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel 
RP. The natural history of the systemic inflammatory response syndrome 
(SIRS). A prospective study. JAMA (1995) 273(2):117–23. doi:10.1001/
jama.273.2.117 
3. Brun-Buisson C. The epidemiology of the systemic inflammatory 
response. Intensive Care Med (2000) 26:S64–74. doi:10.1007/
s001340051121 
4. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endo-
thelial dysfunction in sepsis. Cardiovasc Res (2003) 60:49–57. doi:10.1016/
S0008-6363(03)00397-3 
5. Kotsovolis G, Kallaras K. The role of endothelium and endogenous vasoactive 
substances in sepsis. Hippokratia (2010) 14(2):88–93. 
6. Krüttgen A, Rose-John S. Interleukin-6 in sepsis and capillary leakage syn-
drome. J Interferon Cytokine Res (2012) 32(2):60–5. doi:10.1089/jir.2011.0062 
7. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex 
pattern of cytokines in serum from patients with meningococcal septic shock. 
Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 
(1989) 169(1):333–8. doi:10.1084/jem.169.1.333 
8. Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, Hsiao SM, et al. IL-6 trans-sig-
naling in formation and progression of malignant ascites in ovarian cancer. 
Cancer Res (2011) 71:424–34. doi:10.1158/0008-5472.CAN-10-1496 
9. Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C. Glycocalyx and 
sepsis-induced alterations in vascular permeability. Crit Care (2015) 19:26. 
doi:10.1186/s13054-015-0741-z 
10. Majno G, Palade GE. Studies on inflammation. I. The effect of histamine and 
serotonin on vascular permeability: an electron microscopic study. J Biophys 
Biochem Cytol (1961) 11:571. doi:10.1083/jcb.11.3.571 
11. Majno G, Palade GE, Schoefl G. Studies on inflammation. II. The site of action 
of histamine and serotonin along the vascular tree: a topographic study. 
J Biophys Biochem Cytol (1961) 11:607. doi:10.1083/jcb.11.3.571 
12. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated 
endothelial cell contraction: the relationship between isometric tension, actin 
polymerization, and myosin phosphorylation. J Cell Biol (1995) 130(3):613–
27. doi:10.1083/jcb.130.3.613 
13. Tinsley JH, De Lanerolle P, Wilson E, Ma W, Yuan SY. Myosin light chain 
kinase transference induces myosin light chain activation and endothelial 
hyperpermeability. Am J Physiol Cell Physiol (2000) 279(4):C1285–9. 
14. Yuan Y, Huang Q, Wu HM. Myosin light chain phosphorylation: modulation 
of basal and agonist-stimulated venular permeability. Am J Physiol (1997) 
272(3 Pt 2):H1437–43. 
5Wenceslau et al. Formyl Peptide Receptor and Vascular Leakage
Frontiers in Immunology | www.frontiersin.org August 2016 | Volume 7 | Article 297
15. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. 
Microvasc Res (2009) 77(1):53–63. doi:10.1016/j.mvr.2008.09.012 
16. Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin 
regulation and motility. Cell Adh Migr (2011) 5(2):170–80. doi:10.4161/
cam.5.2.14403 
17. Saarikangas J, Zhao H, Lappalainen P. Regulation of the actin cytoskele-
ton-plasma membrane interplay by phosphoinositides. Physiol Rev (2010) 
90(1):259–89. doi:10.1152/physrev.00036.2009 
18. Gorovoy M, Neamu R, Niu J, Vogel S, Predescu D, Miyoshi J, et al. RhoGDI-1 
modulation of the activity of monomeric RhoGTPase RhoA regulates endo-
thelial barrier function in mouse lungs. Circ Res (2007) 101:50–8. doi:10.1161/
CIRCRESAHA.106.145847 
19. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, Hassoun PM. 
Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on 
MAPK-activated protein kinase MK2. J Biol Chem (2002) 277(45):42596–602. 
doi:10.1074/jbc.M205863200 
20. Wang S, Huang Q, Guo J, Guo X, Sun Q, Brunk UT, et  al. Local thermal 
injury induces general endothelial cell contraction through p38 MAP kinase 
activation. APMIS (2014) 122(9):832–41. doi:10.1111/apm.12226 
21. Wenceslau CF, McCarthy CG, Szasz T, Spitler K, Goulopoulou S, Webb 
RC, et  al. Mitochondrial damage-associated molecular patterns and 
vascular function. Eur Heart J (2014) 35:1172–9. doi:10.1093/eurheartj/
ehu047 
22. Wenceslau CF, McCarthy CG, Szasz T, Goulopoulou S, Webb RC. 
Mitochondrial N-formyl peptides induce cardiovascular collapse and 
sepsis-like syndrome. Am J Physiol Heart Circ Physiol (2015) 308:H768–77. 
doi:10.1152/ajpheart.00779.2014 
23. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Mitochondrial 
DAMPs cause inflammatory responses to injury. Nature (2010) 464:104–7. 
doi:10.1038/nature08780 
24. Wenceslau CF, McCarthy CG, Goulopoulou S, Szasz T, NeSmith EG, 
Webb RC. Mitochondrial-derived N-formyl peptides: novel links between 
trauma, vascular collapse and sepsis. Med Hypotheses (2013) 81(4):532–5. 
doi:10.1016/j.mehy.2013.06.026 
25. Wenceslau CF, Szasz T, McCarthy CG, Baban B, NeSmith E, Webb RC. 
Mitochondrial N-formyl peptides cause airway contraction and lung 
neutrophil infiltration via formyl peptide receptor activation. Pulm Pharmacol 
Ther (2016) 37:49–56. doi:10.1016/j.pupt.2016.02.005 
26. Rabiet MJ, Huet E, Boulay F. Human mitochondria-derived N-formylated 
peptides are novel agonists equally active on FPR and FPRL1, while Listeria 
monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 
(2005) 35:2486–95. doi:10.1002/eji.200526338 
27. Le Y, Murphy PM, Wang JM. Formyl peptide receptors revisited. Trends 
Immunol (2002) 23:541–8. doi:10.1016/S1471-4906(02)02316-5 
28. Li H, Itagaki K, Sandler N, Gallo D, Galenkamp A, Kaczmarek E, et  al. 
Mitochondrial damage-associated molecular patterns from fractures suppress 
pulmonary immune responses via formyl peptide receptors 1 and 2. J Trauma 
Acute Care Surg (2015) 78(2):272–9. doi:10.1097/TA.0000000000000509 
29. Bengtsson T, Stendahl O, Andersson T. The role of the cytosolic free Ca2+ 
transient for fMet-Leu-Phe induced actin polymerization in human neutro-
phils. Eur J Cell Biol (1986) 42(2):338–43. 
30. Glogauer M, Hartwig J, Stossel T. Two pathways through Cdc42 couple the 
N-formyl receptor to actin nucleation in permeabilized human neutrophils. 
J Cell Biol (2000) 150(4):785–96. doi:10.1083/jcb.150.4.785 
31. Makino A, Glogauer M, Bokoch GM, Chien S, Schmid-Schönbein GW. Control 
of neutrophil pseudopods by fluid shear: role of Rho family GTPases. Am 
J Physiol Cell Physiol (2005) 288(4):C863–71. doi:10.1152/ajpcell.00358.2004 
32. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et  al. Mitochondrial 
DAMPs increase endothelial permeability through neutrophil dependent and 
independent pathways. PLoS One (2013) 8(3):e59989. doi:10.1371/journal.
pone.0059989 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Wenceslau, McCarthy and Webb. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (CC BY). 
The use, distribution or reproduction in other forums is permitted, provided the 
original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
